Tevogen, Inc. (TVGN)
6.67
-0.31
(-4.44%)
USD |
NASDAQ |
Oct 05, 16:00
6.67
0.00 (0.00%)
After-Hours: 20:00
Tevogen EPS Diluted (Quarterly) : -1.525 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.525 |
| March 31, 2026 | -1.612 |
| December 31, 2025 | -1.198 |
| September 30, 2025 | -1.496 |
| June 30, 2025 | -1.530 |
| March 31, 2025 | -0.0651 |
| December 31, 2024 | -2.598 |
| September 30, 2024 | -0.0347 |
| June 30, 2024 | -0.0394 |
| March 31, 2024 | -0.2602 |
| December 31, 2023 | -1.514 |
| Date | Value |
|---|---|
| September 30, 2023 | -1.627 |
| June 30, 2023 | -9.244 |
| March 31, 2023 | -12.82 |
| December 31, 2022 | 0.0545 |
| September 30, 2022 | 0.0336 |
| June 30, 2022 | 0.0043 |
| March 31, 2022 | -0.0005 |
| December 31, 2021 | -0.0004 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | -0.0002 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | -1.355 |
| Oncolytics Biotech, Inc. | -0.0788 |
| Sangamo Therapeutics, Inc. | -0.0796 |
| Sarepta Therapeutics, Inc. | -0.0464 |
| Anixa Biosciences, Inc. | -0.0762 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -5.762M |
| Total Expenses (Quarterly) | 5.762M |
| Enterprise Value | 46.86M |
| Earnings Yield | -87.42% |
| Normalized Earnings Yield | -87.68 |